Related Experiment Videos
Chromosome damage induced by carboplatin (CBDCA)
M González Cid1, M Mudry, I Larripa
1Departamento de Genética, Instituto de Investigaciones, Hematológicas Mariano R. Castex, Buenos Aires, Argentina.
Toxicology Letters
|March 1, 1995
Summary
Carboplatin (CBDCA) causes DNA damage in human lymphocytes and Chinese hamster ovary cells, evidenced by increased chromosome aberrations and cell cycle delays. Its DNA-damaging effects are less potent than mitomycin C.
Area of Science:
- Cytogenetics
- Molecular Toxicology
- Cancer Chemotherapy
Background:
- Carboplatin (CBDCA) is a widely used platinum-based chemotherapy agent.
- Understanding its genotoxic potential is crucial for assessing its safety and efficacy.
- Previous studies have indicated potential DNA-damaging properties of platinum compounds.
Purpose of the Study:
- To evaluate the in vitro chromosome damage induced by carboplatin (CBDCA).
- To compare the genotoxic effects of CBDCA with a known DNA-damaging agent, mitomycin C.
- To investigate the impact of CBDCA on cell cycle progression.
Main Methods:
- Human lymphocytes and Chinese hamster ovary (CHO) cells were exposed to varying doses of CBDCA.
- Assays performed included sister chromatid exchange (SCE) analysis, structural chromosome aberration (CA) scoring, and micronucleus (MN) formation assessment.
- Lymphocyte cell cycle progression was monitored.
Main Results:
- CBDCA significantly increased SCE, structural abnormalities, and MN frequency in human lymphocytes.
- A significant increase in CA was observed in CHO cells treated with CBDCA.
- CBDCA caused a notable delay in lymphocyte cycle progression.
- The genotoxic effects of CBDCA were less pronounced compared to mitomycin C.
Conclusions:
- Carboplatin (CBDCA) is a DNA-damaging agent that induces chromosomal aberrations and affects cell cycle progression.
- Its genotoxic profile suggests an alkylating-agent-like mechanism of action.
- The findings contribute to the understanding of carboplatin's genotoxicity in vitro.